Abstract
Radiation therapy is the cornerstone for many of the diseases harbored in the mediastinum, including lymphoma and breast and germ cell tumors. While success is achieved using focused radiation for the obliteration of tumor cells, the insidious and continued damage to surrounding tissues, including heart and lung, has been frequently recognized and represents a unique challenge to the cardiac surgeon and increased risk to the patient. The observational retrospective study from Cleveland Clinic [1] involving 173 patients undergoing a variety of cardiac operations attempts to risk stratify patients using a surrogate marker, the aorto-mitral curtain (AMC) thickness greater than 6 mm as an independent predictor of mortality.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
